RecruitingOBSERVATIONAL

Serological and PCR Testing for COVID-19

The Richmond Research Institute is testing people for COVID-19 using different methods. This includes PCR tests, which show if you currently have the virus, and antibody tests, which can tell if you've had it before and might have some protection. They are tracking infections and immunity within their staff, their families, and visitors. The main goals are to find out how many people have the virus, understand how long immunity might last, and see how effective vaccines are over time. By looking at these things, they aim to gather important information to help prevent the spread of the virus and improve our understanding of COVID-19.

At a glance

Status

Recruiting

Sponsor

Richmond Research Institute

Enrolment target

2,500

Start

16 Mar 2020

Estimated completion

01 Jan 2026

COVID-19

What is this study about?

The Richmond Research Institute (RRI) is carrying out an important study to understand more about COVID-19. They are looking at different ways to test people for the virus. This includes tests that show if someone currently has an active infection, and other tests that can tell if someone has had the virus in the past and developed protective substances called antibodies. Finding reliable and quick ways to test is really important because it helps us know who has the virus, which in turn can help stop it from spreading to others.

The researchers are using these tests to follow what happens with infections and immunity (protection from the virus) in their own staff, their families (including children), and visitors to their site. By collecting all this information, they are building a clearer picture of how COVID-19 affects different people, including those who might not even show symptoms. This data is also helping them understand how well vaccines work over time.

Ultimately, this study aims to help us detect the virus earlier, understand how long people might be immune, and identify individuals who have the virus but don't feel sick. This information is key to making sure people get the right care, helping them to self-isolate when needed, and reducing the overall spread of COVID-19 in our communities.

Key takeaways

Researchers are testing new ways to detect COVID-19 infection and past exposure.
The study aims to understand how COVID-19 spreads and how long immunity lasts.
Both current infections (PCR tests) and past infections (antibody tests) are being monitored.
Information gathered will help improve public health strategies and develop better tests.
Participants can be between 5 and 70 years old.

Who may be eligible?

To be part of this study, you need to be a man or a woman between 5 and 70 years old. You must also be able to understand the study, be willing to follow all the steps involved, and agree to do so.

There are no specific reasons listed that would prevent someone from joining this particular study, as long as they meet the age and understanding requirements.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you between 5 and 70 years old?
Do you understand what the study involves?
Are you willing to follow all the study's instructions?
Are you happy to have blood tests and swabs taken?

Answer every question to see your result.

What does participation involve?

If you take part in this study, you will have various tests done, likely including a PCR test (which usually involves a swab from your nose or throat) to check for current infection, and blood tests to look for antibodies (which show if you've had the virus before). The study aims to involve you over time to see how your infection or antibody levels change. The full duration of your participation isn't specified, but because they are looking at how things change over time and how long immunity lasts, it suggests you would be re-tested at different points.

Potential risks and benefits

A potential benefit of joining this study is gaining early knowledge about whether you currently have COVID-19 or if you've had it in the past. This information empowers you to make informed decisions for your health and to help protect others. The risks associated with the tests are generally low, mainly discomfort from swabs or blood draws. You always have the right to withdraw from the study at any time without giving a reason, and this will not affect any medical care you might receive.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge
Verified postcode
London, United Kingdom· Recruiting

Common questions

What is the study trying to find out?

This study is trying to find better ways to test for COVID-19, understand how long people are immune after having the virus or a vaccine, and see how many people carry the virus without symptoms.

What is an 'antibody test'?

An antibody test is usually a blood test that looks for special proteins your body makes to fight off infections like COVID-19. Finding these antibodies can mean you've had the virus in the past.

What is a 'PCR test'?

A PCR test checks for the actual virus itself, usually from a swab inside your nose or throat. It's used to see if you have an active COVID-19 infection right now.

Will I find out my test results?

The study aims to help you understand your infection status, so it's likely you would be informed of your individual results, but this is something to confirm with the study team.

Who can join this study?

People aged between 5 and 70 who can understand and agree to follow the study procedures can join.

How to find out more

Jorg Taubel, MD

j.taubel@richmondpharmacology.com +44(0)2070425800 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.